湖北亨迪药业股份有限公司(301211.SZ) 始创于1995年，是中国领先的CDMO服务企业和特色原料药生产企业，荆门和武汉两个基地共十二次通过欧美官方检查认证，客户遍及全世界90多个国家和地区。30年来向全球跨国药企和新药研创公司提供CDMO/CMO服务，提供原料药从新药临床前药学研究、各阶段临床到商业化生产的一站式服务。总反应能力约1000立方，涵盖多个OEB4-5高活性GMP生产线，反应釜体积5L~5000L，能承接从克、公斤、吨、百吨、千吨等不同规模的小分子原料药及中间体的合同研发与生产业务。

Hubei Heilen Pharmaceutical Co., Ltd. (stock code: 301211. SZ), established in 1995, is a leading enterprise of CDMO service and generic API production in China. Jingmen and Wuhan sites were approved by EU & US official inspection for 12 times, supporting global customers in more than 90 countries and regions. During past 30 years, we have provided CDMO/CMO services to global pharmaceutical companies and new drug R&D companies. We are able to provide one-stop API services for global clients, including preclinical pharmaceutical research for new drugs, research and development and production of API at clinical and various stages, and commercial production. The total reaction capacity is about 1000M³, covering multiple OEB4-5 Highly Potent API GMP production lines, with a reactor volume of 5L~5000L. It can undertake CDMO/CMO business of small molecule APIs and intermediates of different scales from grams/kilos to thousands of tons.